DOXORUBICINVIGEVANI A; WILLIAMSON MJ.1980; ANAL. PROFILES DRUG SUBST.; ISSN 0099-5428; USA; DA. 1980; VOL. 9; PP. 245-274; BIBL. 55 REF.Article

INTRODUCTION: ANTHRACYCLINE DERIVATIVES IN NEW DRUG DEVELOPMENT PROGRAMSROZENCWEIG M; DE SLOOVER C; VON HOFF DD et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 807-808; BIBL. 3 REF.Article

COMPLICATIONS CARDIAQUES DE LA CHIMIOTHERAPIE ET DE LA RADIOTHERAPIEOLIVE D.1981; ARCH. FR. PEDIATR.; ISSN 0003-9764; FRA; DA. 1981; VOL. 38; NO 5; PP. 379-384; BIBL. 65 REF.Article

THE STRUCTURE OF BAUMYCINS A₁, A₂, B₁, B₂, C₁ AND C₂.TAKAHASHI Y; NAGANAWA H; TAKEUCHI T et al.1977; J. ANTIBIOT.; JAP.; DA. 1977; VOL. 30; NO 7; PP. 622-624; BIBL. 2 REF.Article

NEW SYSTEMS FOR DETECTION OF ANTITUMOR DRUGS.1978; ANTIBIOT. AND CHEMOTHERAPY; SWITZ.; DA. 1978; VOL. 23; PP. 4-41; BIBL. DISSEM.Article

NEW ANTITUMOR ANTIBIOTICS: MUSETTAMYCIN AND MARCELLOMYCIN FROM BOHEMIC ACID COMPLEX.NETTLETON DE JR; BRADNER WT; BUSH JA et al.1977; J. ANTIBIOT.; JAP.; DA. 1977; VOL. 30; NO 6; PP. 525-529; BIBL. 6 REF.Article

DNA, LIPOSOMES, AND PROTEINS AS CARRIERS FOR ANTITUMORAL DRUGSTROUET A; BAURAIN R; DEPREZ DE CAMPENEERE D et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 75; PP. 229-235; BIBL. 7 REF.Article

EXTRAVASATION OF CHEMOTHERAPEUTIC AGENTSBLAIR WF; KILPATRICK WC JR; SAIKI JH et al.1980; CLIN. ORTHOP. RELAT. RES.; ISSN 0009-921X; USA; DA. 1980; NO 151; PP. 228-230; BIBL. 9 REF.Article

ADRIAMYCIN CARDIAC TOXICITY. A DIFFERENT HYPOTHESIS.BYFIELD JE.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 3; PP. 497-498; BIBL. 15 REF.Article

TOXICOLOGIC SCREENING OF DAUNORUBICIN (NSC-82151), ADRIAMYCIN (NSC-123127), AND THEIR DERIVATIVES IN RATS.ZBINDEN G; BRANDLE E.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 4; PP. 707-715; BIBL. 23 REF.Article

STRUCTURE-ACTIVITY RELATIONSHIPS OF ANTHRACYCLINES RELATIVE TO EFFECTS ON MACROMOLECULAR SYNTHESES.CROOKE ST; DUVERNAY VH; GALVAN L et al.1978; MOLEC. PHARMACOL.; U.S.A.; DA. 1978; VOL. 14; NO 2; PP. 290-298; BIBL. 21 REF.Article

RAPID DETERMINATION OF DOXORUBICIN AND ITS FLUORESCENT METABOLITES BY HIGH PRESSURE LIQUID CHROMATOGRAPHYBAURAIN R; DEPREZ DE CAMPENEERE D; TROUET A et al.1979; ANAL. BIOCHEM.; USA; DA. 1979; VOL. 94; NO 1; PP. 112-116; BIBL. 11 REF.Article

STRUCTURE-ACTIVITY RELATIONSHIPS AMONG DAUNORUBICIN AND ADRIAMYCIN ANALOGSHENRY DW.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 845-854; BIBL. 23 REF.Article

A PAUCITY OF CHRONIC ELECTROCARDIOGRAPHIC CHANGES WITH ADRIAMYCIN THERAPYWEAVER SK; FULKERSON PK; LEWIS RP et al.1978; J. ELECTROCARDIOL.; USA; DA. 1978; VOL. 11; NO 3; PP. 233-238; BIBL. 13 REF.Article

Discovery and development of anthracycline antitumor antibioticsLOWN, J. W.Chemical Society reviews (Print). 1993, Vol 22, Num 3, pp 165-176, issn 0306-0012Article

DAUNORUBICIN AND PLATELET FUNCTIONPOGLIANI EM; FANTASIA R; LAMBERTENGHI DELILIERS G et al.1981; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1981; VOL. 45; NO 1; PP. 38-42; BIBL. 21 REF.Article

PNEUMOTHORAX DURING COMBINATION CHEMOTHERAPYLOTE K; DAHL O; VIGANDER T et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 7; PP. 1743-1745; BIBL. 18 REF.Article

REDUCTION OF DAUNOMYCIN TOXICITY BY RAZOXANEWANG G; FINCH MD; TREVAN D et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 43; NO 6; PP. 871-877; BIBL. 5 REF.Article

THE PREPARATION OF MITOMYCIN C, ADRIAMYCIN AND DAUNOMYCIN COVALENTLY BOUND TO ANTIBODIES AS IMPROVED CANCER CHEMOTHERAPEUTIC AGENTSSUZUKI T; SATO E; GOTO K et al.1981; CHEM. PHARM. BULL.; ISSN 0009-2363; JPN; DA. 1981; VOL. 29; NO 3; PP. 844-848; BIBL. 9 REF.Article

ANTAGONISM OF DOXORUBICIN CARDIOTOXICITY BY CARNITINE IS SPECIFIC OF THE L-DIASTEROISOMERMACCARI F; RAMACCI MT.1981; BIOMEDICINE; FRA; DA. 1981; VOL. 35; NO 2; PP. 65-67; ABS. FRE; BIBL. 20 REF.Article

LATE, LATE DOXORUBICIN CARDIOTOXICITYGOTTLIEB SL; EDMISTON WA JR; HAYWOOD LJ et al.1980; CHEST; ISSN 0012-3692; USA; DA. 1980; VOL. 78; NO 6; PP. 880-882; BIBL. 8 REF.Article

PRELIMINARY CLINICAL STUDY OF ACLACINOMYCIN AMAJIMA H.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 75-81; BIBL. 3 REF.Conference Paper

ANTIHEPARIN ACTIVITY OF ADRIAMYCINCOFRANCESCO E; VIGO A; POGLIANI E et al.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 5; PP. 743-746; BIBL. 12 REF.Article

DAUNORUBICIN AND ADRIAMYCIN IN CANCER TREATMENT; AN ANALYSIS OF THEIR ROLES AND LIMITATIONSDAVIS HL; DAVIS TE.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 809-815; BIBL. 48 REF.Article

INHIBITION OF DRUG OXIDATION AND STIMULATION OF NADPH OXIDASE IN VITRO BY DOXORUBICIN AND TRIFERRIC-DOXORUBICINVAN BOXTEL CJ; CHRASTIL J; WILSON JT et al.1979; PHARMACOLOGY; CHE; DA. 1979; VOL. 19; NO 1; PP. 5-11; BIBL. 14 REF.Article